RXST logo

RxSight (RXST) Cash From Operations

Annual CFO

-$41.59 M
+$17.26 M+29.32%

December 31, 2023

Summary

Performance

1-Year Change

+29.32%

3-Year Change

-18.15%

5-Year Change

-2.4%

15-Year Change

-2.4%

RXST Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

31.1%
RXST annual cash flow from operations is higher than 31.1% of companies in Healthcare sector

High & Low

All-time High

-$35.20 M

3-Year Low

-$58.85 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RXST previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
RXST next annual earnings announcement is scheduled for Feb 28, 2025

OtherRXSTcash flowmetrics:

Annual CFI

-$22.13 M
RXST annual cash flow from investing activities is -$22.13 million

Annual CFF

$61.52 M
RXST annual cash flow from financing activities is $61.52 million

Annual FCF

-$46.41 M
RXST annual free cash flow is -$46.41 million

Annual CAPEX

$4.81 M
RXST annual capital expenditures is $4.81 million

Quarterly CFO

$650.00 K
+$4.68 M+116.14%

September 30, 2024

Summary

Performance

3-Month Change

+116.14%

1-Year Change

+107.83%

3-Year Change

+107.83%

5-Year Change

+107.83%

RXST Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

74.67%
RXST quarterly cash flow from operations is higher than 74.67% of companies in Healthcare sector

High & Low

All-time High

$650.00 K
RXST quarterly cash flow from operations is currently at an all-time high

3-Year Low

-$17.76 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RXST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RXST next earnings announcement is scheduled for Feb 28, 2025

OtherRXSTcash flowmetrics:

Quarterly CFI

-$9.26 M
RXST quarterly cash flow from investing activities is -$9.26 million

Quarterly CFF

$878.00 K
RXST quarterly cash flow from financing activities is $878.00 thousand

Quarterly FCF

-$453.00 K
RXST quarterly free cash flow is -$453.00 thousand

Quarterly CAPEX

$1.10 M
RXST quarterly capital expenditures is $1.10 million

TTM CFO

-$20.99 M
+$8.63 M+29.14%

September 30, 2024

Summary

Performance

3-Month Change

+29.14%

1-Year Change

+49.54%

3-Year Change

+49.54%

5-Year Change

+49.54%

RXST TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

44.63%
RXST TTM cash flow from operations is higher than 44.63% of companies in Healthcare sector

High & Low

All-time High

-$12.22 M

3-Year Low

-$61.63 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RXST previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
RXST next earnings announcement is scheduled for Feb 28, 2025

OtherRXSTcash flowmetrics:

TTM CFI

-$96.06 M
RXST TTM cash flow from investing activities is -$96.06 million

TTM CFF

$123.91 M
RXST TTM cash flow from financing activities is $123.91 million

TTM FCF

-$27.17 M
RXST TTM free cash flow is -$27.17 million

TTM CAPEX

$6.18 M
RXST TTM capital expenditures is $6.18 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

RXST Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.3%+107.8%+49.5%
3 y3 years-18.1%+107.8%+49.5%
5 y5 years-2.4%+107.8%+49.5%

RXST Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+29.3%at high+103.7%at high+66.0%
5 y5-year-18.1%+29.3%at high+103.7%-71.8%+66.0%
alltimeall time-18.1%+29.3%at high+103.7%-71.8%+66.0%

RxSight Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
$650.00 K(-116.1%)
-$20.99 M(-29.1%)
Jun 2024
-
-$4.03 M(-56.7%)
-$29.62 M(-10.6%)
Mar 2024
-
-$9.31 M(+12.1%)
-$33.14 M(-20.3%)
Dec 2023
-$41.59 M(-29.3%)
-$8.30 M(+4.0%)
-$41.59 M(-11.8%)
Sep 2023
-
-$7.98 M(+5.8%)
-$47.15 M(-13.3%)
Jun 2023
-
-$7.55 M(-57.5%)
-$54.35 M(-11.8%)
Mar 2023
-
-$17.76 M(+28.2%)
-$61.63 M(+4.7%)
Dec 2022
-$58.85 M
-$13.85 M(-8.8%)
-$58.85 M(+9.6%)
Sep 2022
-
-$15.19 M(+2.5%)
-$53.72 M(+2.7%)
Jun 2022
-
-$14.82 M(-1.1%)
-$52.28 M(+5.8%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$14.98 M(+71.8%)
-$49.44 M(+10.6%)
Dec 2021
-$44.71 M(+27.0%)
-$8.72 M(-36.6%)
-$44.71 M(+1.1%)
Sep 2021
-
-$13.76 M(+14.8%)
-$44.21 M(+18.2%)
Jun 2021
-
-$11.98 M(+16.8%)
-$37.41 M(+12.5%)
Mar 2021
-
-$10.25 M(+24.6%)
-$33.24 M(-5.6%)
Dec 2020
-$35.20 M(-13.3%)
-$8.23 M(+18.4%)
-$35.20 M(+30.5%)
Sep 2020
-
-$6.95 M(-11.0%)
-$26.98 M(+34.7%)
Jun 2020
-
-$7.81 M(-36.1%)
-$20.03 M(+63.9%)
Mar 2020
-
-$12.22 M
-$12.22 M
Dec 2019
-$40.62 M
-
-

FAQ

  • What is RxSight annual cash flow from operations?
  • What is the all time high annual CFO for RxSight?
  • What is RxSight annual CFO year-on-year change?
  • What is RxSight quarterly cash flow from operations?
  • What is the all time high quarterly CFO for RxSight?
  • What is RxSight quarterly CFO year-on-year change?
  • What is RxSight TTM cash flow from operations?
  • What is the all time high TTM CFO for RxSight?
  • What is RxSight TTM CFO year-on-year change?

What is RxSight annual cash flow from operations?

The current annual CFO of RXST is -$41.59 M

What is the all time high annual CFO for RxSight?

RxSight all-time high annual cash flow from operations is -$35.20 M

What is RxSight annual CFO year-on-year change?

Over the past year, RXST annual cash flow from operations has changed by +$17.26 M (+29.32%)

What is RxSight quarterly cash flow from operations?

The current quarterly CFO of RXST is $650.00 K

What is the all time high quarterly CFO for RxSight?

RxSight all-time high quarterly cash flow from operations is $650.00 K

What is RxSight quarterly CFO year-on-year change?

Over the past year, RXST quarterly cash flow from operations has changed by +$8.95 M (+107.83%)

What is RxSight TTM cash flow from operations?

The current TTM CFO of RXST is -$20.99 M

What is the all time high TTM CFO for RxSight?

RxSight all-time high TTM cash flow from operations is -$12.22 M

What is RxSight TTM CFO year-on-year change?

Over the past year, RXST TTM cash flow from operations has changed by +$20.61 M (+49.54%)